BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22093271)

  • 1. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.
    Bucerius J; Duivenvoorden R; Mani V; Moncrieff C; Rudd JH; Calcagno C; Machac J; Fuster V; Farkouh ME; Fayad ZA
    JACC Cardiovasc Imaging; 2011 Nov; 4(11):1195-205. PubMed ID: 22093271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake.
    Bucerius J; Mani V; Moncrieff C; Rudd JH; Machac J; Fuster V; Farkouh ME; Fayad ZA
    J Am Coll Cardiol; 2012 Jun; 59(23):2080-8. PubMed ID: 22651864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
    Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
    Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
    Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study.
    Strobl FF; Rominger A; Wolpers S; Rist C; Bamberg F; Thierfelder KM; Nikolaou K; Uebleis C; Hacker M; Reiser MF; Saam T
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1899-908. PubMed ID: 23979062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries.
    Silvera SS; Aidi HE; Rudd JH; Mani V; Yang L; Farkouh M; Fuster V; Fayad ZA
    Atherosclerosis; 2009 Nov; 207(1):139-43. PubMed ID: 19467659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
    Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
    Duivenvoorden R; Mani V; Woodward M; Kallend D; Suchankova G; Fuster V; Rudd JHF; Tawakol A; Farkouh ME; Fayad ZA
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography.
    Kim TN; Kim S; Yang SJ; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Circ Cardiovasc Imaging; 2010 Mar; 3(2):142-8. PubMed ID: 20061516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.
    Lei-xing X; Jing-jing G; Jing-xue N; Juan W; Juan L; Chang-zai L; Xiao-xi W; Da-yi Y; Jia-jin L; Xiong-wei Z; Liu-quan C; Yong W; Dan-qing L; Hong-bin L
    J Int Med Res; 2014 Feb; 42(1):213-23. PubMed ID: 24366494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased microvascularization and vessel permeability associate with active inflammation in human atheromata.
    Taqueti VR; Di Carli MF; Jerosch-Herold M; Sukhova GK; Murthy VL; Folco EJ; Kwong RY; Ozaki CK; Belkin M; Nahrendorf M; Weissleder R; Libby P
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):920-9. PubMed ID: 25170063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
    deGoma EM; Salavati A; Shinohara RT; Saboury B; Pollan L; Schoen M; Torigian DA; Mohler ER; Dunbar RL; Litt HI; Woo J; Rader DJ; Alavi A; Mehta NN
    Acad Radiol; 2015 May; 22(5):600-9. PubMed ID: 25708866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
    Figueroa AL; Abdelbaky A; Truong QA; Corsini E; MacNabb MH; Lavender ZR; Lawler MA; Grinspoon SK; Brady TJ; Nasir K; Hoffmann U; Tawakol A
    JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study.
    Mani V; Woodward M; Samber D; Bucerius J; Tawakol A; Kallend D; Rudd JH; Abt M; Fayad ZA
    Int J Cardiovasc Imaging; 2014 Mar; 30(3):571-82. PubMed ID: 24458953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
    Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
    J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid PET- and MR-driven attenuation correction for enhanced
    Karakatsanis NA; Abgral R; Trivieri MG; Dweck MR; Robson PM; Calcagno C; Boeykens G; Senders ML; Mulder WJM; Tsoumpas C; Fayad ZA
    J Nucl Cardiol; 2020 Aug; 27(4):1126-1141. PubMed ID: 31667675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thresholds for Arterial Wall Inflammation Quantified by
    van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of F-18 FDG and ultrasound analysis of carotid plaque.
    Choi YS; Youn HJ; Chung WB; Hwang HJ; Lee DH; Park CS; Lee JB; Kim PJ; Chung WS; Lee MY; Seung KB; Chung YA
    J Nucl Cardiol; 2011 Apr; 18(2):267-72. PubMed ID: 21279492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.